ClinicalTrials.Veeva

Menu

Model for Prognosis of Elderly Gastric Cancer Patients

C

Chang-Ming Huang, Prof.

Status

Completed

Conditions

Aged
Stomach Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT06393153
2024KY074

Details and patient eligibility

About

This study aims to develop and validate a Random Survival Forest (RSF) model for predicting long-term survival in elderly patients following curative resection for gastric cancer. The study is a retrospective multi-center analysis involving patients aged 75 and above who underwent gastric resection from January 2009 to December 2018 at nine top-tier hospitals in China. An online prognostic tool is introduced to assist clinicians in predicting patient prognosis and customizing treatment and follow-up strategies.

Full description

This retrospective multi-center study focuses on the development and validation of a predictive model for elderly gastric cancer patients. Data were collected from 16,344 gastric cancer patients, with 1,202 elderly patients ultimately included after applying exclusion criteria. Patients were randomly divided into training and testing cohorts in a 7:3 ratio. The study was approved by the institutional review boards with a waiver of informed consent due to the use of anonymized secondary data.

The analysis employs the Random Survival Forest (RSF) method, incorporating variable importance and minimal depth techniques to select key variables for predicting overall survival (OS) and disease-free survival (DFS). The study also implements rigorous data handling procedures, including multiple imputations for missing data.

The development of an online prognostic tool based on the RSF model is part of the project, designed to provide real-time survival predictions through a user-friendly interface for clinical application.

Enrollment

1,202 patients

Sex

All

Ages

75+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 75 years or older.
  • Histologically confirmed diagnosis of gastric cancer.
  • Patients who have undergone curative gastrectomy.

Exclusion criteria

  • Patients with non-primary gastric malignancies.
  • Pathological confirmation of metastatic disease (M1).
  • Incomplete follow-up data or loss to follow-up.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems